Progesterone: Clinical Trials

330 trials of Progesterone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

190 completed, 60 unknown, 26 terminated, 24 recruiting. 90 Phase 4, 76 Not applicable, 60 Phase 2, 60 Phase 3, 30 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 490Completed 52, Unknown 20, Recruiting 9, Not yet recruiting 3, Terminated 3, Withdrawn 3
Not applicable76Completed 35, Unknown 17, Terminated 9, Withdrawn 5, Recruiting 4, Not yet recruiting 3, Active not recruiting 1, Enrolling by invitation 1, Suspended 1
Phase 260Completed 37, Unknown 13, Terminated 5, Recruiting 2, Withdrawn 2, Suspended 1
Phase 360Completed 39, Withdrawn 7, Terminated 6, Unknown 4, Recruiting 3, Not yet recruiting 1
Phase 130Completed 18, Terminated 4, Unknown 3, Not yet recruiting 2, Recruiting 2, Suspended 1
Early Phase 112Unknown 5, Completed 4, Recruiting 2, Terminated 1

Follow Progesterone: new trials by email Literature Review of Progesterone trials Research Report on Progesterone

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cycle-to-cycle Variability of Progesterone in the Endometrium in Patients Undergoing an Euploid Blastocyst Transfer in a Hormone Replacement Therapy (HRT) Cycle (PROMICOFET)
Oestrogel® 0.75 mg (estradiol transdermal gel), Progesterone 200 mg vaginal capsules, Endometrial biopsy - Fertility, Implantation, Embryo
Phase 4Not yet recruitingUniversity Hospital, Ghent702026-10-012026-09-14
Oral GnRH Antagonist (Linzagolix) Versus Injectable GnRH Antagonist in Controlled Ovarian Stimulation for In Vitro Fertilization: A Randomized Controlled Non-Inferiority Trial With a Concurrent Comparator Cohort Undergoing Progestin-Primed Ovarian Stimulation (PPOS)
Ganirelix ; Cetrorelix, Medroxyprogesterone Acetate ; Micronized Progesterone, Linzagolix - Infertility, Female, Ovulation Induction
Not applicableNot yet recruitingCentro A.M.B.R.A. (Associazione Medici e Biologi per la Riproduzione Assistita)1202026-09-012026-09-30
Comparing the Pharmacokinetics of a Progesterone Ring Versus a Progesterone Vaginal Insert
Progesterone - Pre Term Birth
Phase 1Not yet recruitingDaré Bioscience, Inc.602026-09-012026-05-08
Azithromycin for Cerclage Prophylaxis
Azithromycin Prophylaxis, Azithromycin Placebo, Cefazolin - Cervical Insufficiency
Phase 4Not yet recruitingWake Forest University Health Sciences802026-09-012026-08-27
Progesterone Supplementation After Letrozole-stimulated Insemination
Progesterone - Infertility
Phase 4RecruitingKirstine Kirkegaard6902026-08-282026-09-09
Exogenous Progesterone as Ovulation Trigger
Vaginal micronized progesterone - Ovulation, Ovarian Function
Phase 4Not yet recruitingInstituto Valenciano de Infertilidade de Lisboa102026-07-012026-06-04
GnRH for Luteal Support - Mechanism of Action
GnRH agonist, Progesterone - GnRH Antagonist IVF Protocol, Fresh Embryo Transfer
RecruitingHeli Alexandroni1502026-05-182026-06-02
First in Human Safety and Ease of Use Assessment of 400mg Progesterone Callavid in Women With Luteal Phase Insufficiency
400mg progesterone Callavid - 2hr wear, Cyclogest 400 mg, 400mg progesterone Callavid - 3hr wear - Luteal Phase Insuffiency, Progesterone Delivery
Phase 1RecruitingCalla Lily Clinical Care Ltd202026-04-202026-09-10
Cerclage Plus Progesterone vs Progesterone Alone in Twin Short Cervix
Cervical cerclage, Progesterone - Preterm
Not applicableRecruitingNational Hospital of Obstetrics and Gynecology2602026-04-102026-04-24
Menopausal HT for Women Living With HIV (HoT)
Transdermal estradiol gel, Micronized Progesterone, Placebo for estradiol gel - HIV Infection, Menopause
Phase 4RecruitingAdvancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections1052026-04-092026-05-22
Comparison of Oral Dydrogesterone and Vaginal Progesterone in Menopausal Hormone Therapy
Dydrogesterone 10 MG Oral Tablet, Micronized progesterone 200 MG, Transdermal estradiol - Menopausal Women, Menopausal Symptom Relief
Not applicableNot yet recruitingSehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital2002026-04-012026-03-27
FET-LET-2x2: Clinical Pregnancy Rates After Frozen Embryo Transfer in Natural and Modified Natural Cycles
Letrozole (Aromatase Inhibitors), Choriogonadotropin alpha (r-hCG), Progesterone - Infertility Female, Frozen Embryo Transfer (FET)
Not applicableRecruitingUniversity of Novi Sad1202026-03-132026-09-29
Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes
Testosterone Enanthate, Testosterone Cypionate, Testosterone Propionate - Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes
Not applicableEnrolling by invitationEnhanced Emirates Limited602026-03-122026-05-06
Progesterone and Muscle Protein Synthesis in Premenopausal Women (MP4-MPS)
Micronized progesterone (oral capsules), placebo capsule - Healthy Volunteers, Female
Phase 1CompletedMcMaster University202026-01-012026-06-17
Effect of Progesterone Administration on Severely Head Injured Patients
Progesterone, The usual head trauma care - Severe Head Trauma
Phase 1Not yet recruitingAssiut University502025-12-012025-06-25
An Open-label, Randomized, Single-dose, Two-treatment, Four-period, Fully Replicate Crossover Bioequivalence Study in Healthy Female Adult Participants Under Fasting Conditions Comparing the Test Product, Prontogest Solution for IM Injection With the Reference Product, Progesterone Injection
Progesterone IM of 100 mg - Bioequivalance, Post-menopause
Phase 1CompletedZi Diligence Biocenter262025-11-102026-03-27
Nintedanib for Improving Reproductive Outcomes in Adenomyosis
Nintedanib, Progesterone - Adenomyosis of Uterus
Phase 3Not yet recruitingSun Yat-sen University3282025-09-012025-09-09
Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome
Micronized progesterone 200 MG, Micronized Progesterone 100 MG - Turner Syndrome, Primary Ovarian Insufficiency (Poi)
Phase 4RecruitingChildren's Mercy Hospital Kansas City402025-07-312026-08-25
Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency
Progesterone, Estrogen Patch - Premature Ovarian Insufficiency
Phase 3RecruitingEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1852025-07-172026-10-21
Progesterone in Gender Affirming Hormone Therapy Study
Placebo, Progesterone - Transgender Women
Phase 2RecruitingEmory University402025-05-122025-12-24

Showing 20 of 330. Sign in to see all of them.

Conditions studied

Infertility (49)  ·  Premature Birth (37)  ·  Infertility, Female (19)  ·  Polycystic Ovary Syndrome (17)  ·  Obstetric Labor, Premature (14)  ·  Tobacco Use Disorder (10)  ·  Depression (9)  ·  Abortion, Spontaneous (7)  ·  Cardiovascular Diseases (7)  ·  Coronary Disease (6)  ·  Hyperandrogenism (6)  ·  Amenorrhea (5)  ·  Cocaine-Related Disorders (5)  ·  Hot Flashes (5)  ·  Osteoporosis (5)

Sponsors

University of Virginia (11)  ·  University of North Carolina, Chapel Hill (10)  ·  Organon and Co (9)  ·  Universitair Ziekenhuis Brussel (8)  ·  Yale University (8)  ·  University of Minnesota (7)  ·  IBSA Institut Biochimique SA (6)  ·  ART Fertility Clinics LLC (4)  ·  Ain Shams University (4)  ·  CRG UZ Brussel (4)  ·  Ferring Pharmaceuticals (4)  ·  Indiana University (4)  ·  Instituto Valenciano de Infertilidad, IVI VALENCIA (4)  ·  Massachusetts General Hospital (4)  ·  Mỹ Đức Hospital (4)

Countries

United States (122)  ·  Egypt (27)  ·  Israel (20)  ·  China (17)  ·  Belgium (13)  ·  Spain (13)  ·  Canada (11)  ·  Italy (9)  ·  United Kingdom (8)  ·  Denmark (7)  ·  Brazil (6)  ·  Germany (6)  ·  Vietnam (6)  ·  Austria (5)  ·  Russia (5)

Top investigators

Christopher R. McCartney, MD (3)  ·  James E Tisdale, PharmD (3)  ·  Nancy K Mello, PhD (3)  ·  Peter J Schmidt, M.D. (3)  ·  Susan Girdler, PhD (3)  ·  Ahmed M Badawy, Prof (2)  ·  Andrew Combs, MD (2)  ·  Crystal E Schiller, PhD (2)  ·  Jerilynn C Prior, MD, FRCPC (2)  ·  John C. Marshall, MD, PhD (2)  ·  Mohamed S Abdelhafez, Dr (2)  ·  Sanjay Asthana, MD (2)

Results publications

PMID 22587997, PMID 26950065, PMID 26991902, PMID 36453699, PMID 22459628, PMID 25209926, PMID 28044059, PMID 28786978, PMID 29338855, PMID 30184299, PMID 30741812, PMID 30895243, PMID 31248618, PMID 33307906, PMID 34035477, PMID 39982935, PMID 10221715, PMID 12413988, PMID 14714588, PMID 15036255, PMID 15901745, PMID 17011666, PMID 17195882, PMID 17573392, PMID 17826908, PMID 17899571, PMID 17899572, PMID 18191855, PMID 18275573, PMID 19246470, PMID 19657788, PMID 19684043, PMID 19918965, PMID 19996872, PMID 20097333, PMID 20108447, PMID 20483664, PMID 20539042, PMID 20579989, PMID 20719809, PMID 20843746, PMID 20869038, PMID 21411543, PMID 21472815, PMID 21622693, PMID 21665546, PMID 21698665, PMID 21739497, PMID 21739499, PMID 21816790

NIH funding

2004 (5), U54HD028934 (5), P50HD028934 (4), 2018 (2), R01HD058671 (2), 2005 (1), 2009 (1), 2025 (1), K12HD001441 (1), K23HL077179 (1), K23MH105569 (1), K24DA030301 (1), K24DA038240 (1), K99MH109667 (1), N01HV68165 (1)